Exchange Traded Concepts, LLC Ngm Biopharmaceuticals Inc Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
BUY
$1.17 - $1.92 $92,679 - $152,088
79,213 Added 74.02%
186,232 $296,000
Q4 2023

Jan 05, 2024
BUY
$0.6 - $1.31 $16,282 - $35,549
27,137 Added 33.97%
107,019 $92,000
Q3 2023

Oct 18, 2023
BUY
$1.05 - $3.37 $42,069 - $135,022
40,066 Added 100.63%
79,882 $85,000
Q2 2023

Jul 20, 2023
BUY
$2.44 - $4.53 $97,151 - $180,366
39,816 New
39,816 $103,000

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email